Related by context. Frequent words. (Click for all words.) 73 Callisto Pharmaceuticals Inc. 71 Initiates Phase II 69 Synergy Pharmaceuticals 69 EPIX Pharmaceuticals Inc. 69 Presents Positive 69 Inc. Nasdaq IMGN 68 Genaera Corporation 67 Connetics Corporation 67 Inc Therapeutic Competitors 67 Nasdaq ENZN 66 NASDAQ CRXL 66 Urigen Pharmaceuticals Inc. 66 NovaBay Pharmaceuticals 66 Novelos Therapeutics Inc. 66 BioMarin develops 65 Metabasis Therapeutics Inc. 65 Bayhill Therapeutics 65 Completes Enrollment 64 immuno inflammatory diseases 64 Nasdaq VRTX 64 Report companiesandmarkets.com adds 64 Inc. Nasdaq SEPR 64 Advancing Drugs 64 Files Shelf Registration Statement 64 NASDAQ IMCL 64 Celsion Corporation 64 Crucell NV Euronext 64 NASDAQ LGND 64 commercializing therapeutic 64 Archemix Corp. 63 Announces Initiation 63 Cerus Corporation 63 NovaBay Pharmaceuticals Inc. 63 please visit http:/www.supergen.com 63 Adeona Pharmaceuticals Inc. 63 Nasdaq ADLR 63 Immunicon Corporation 63 Nasdaq REGN 63 Announces Presentation 63 OncoGenex Pharmaceuticals Inc. 63 Idera Pharmaceuticals 63 Healthnostics Inc. 63 submitted Biologics License 63 AVEO Pharmaceuticals 63 NASDAQ CYPB 63 Company Nasdaq PRGO 63 commercializes innovative biopharmaceuticals 63 Initiates Phase 63 Alseres Pharmaceuticals Inc. 63 ImmuneRegen BioSciences Inc. 63 Corautus Genetics Inc. 63 Fibrocell Science Inc. 62 Inc. NASDAQ TRGT 62 Nasdaq ASTM 62 Aradigm Corporation 62 SANUWAVE Health 62 Transcept Pharmaceuticals 62 Peptimmune 62 NASDAQ SHPGY 62 Inc. NASDAQ MRNA 62 Intellect Neurosciences Inc. 62 DRRX 62 FDA Accepts 62 MorphoSys AG FSE MOR 62 Announces FDA Clearance 62 BioSpecifics Technologies Corp. 62 EntreMed Inc. 62 OTCBB AEMD 62 Preclinical Development 62 Barrier Therapeutics Inc. 61 NASDAQ CBST 61 Rexahn Pharmaceuticals Inc. 61 Nasdaq BDSI 61 Iomai Corporation 61 TSX VENTURE IMV 61 Drug Candidate 61 Takeda Kyowa Hakko Kirin 61 Genelabs Technologies Inc. 61 addressing idiopathic pulmonary 61 VioQuest Pharmaceuticals 61 DOR BioPharma Inc. 61 Inc. NASDAQ QLTI 61 Nasdaq ALTH 61 Medtech Insight division 61 Cyclacel Pharmaceuticals Inc. 61 refractory chronic lymphocytic 61 AVANT Immunotherapeutics Inc. 61 RegeneRx Biopharmaceuticals Inc. 61 Regado Biosciences 61 immunologic diseases 61 Regains Compliance With 61 Adherex Technologies Inc. 61 Pluristem Therapeutics Inc. 61 R sorafenib tablets 61 VIA Pharmaceuticals 61 Hybridon 61 Vicor Technologies Inc. 61 HAYWARD Calif. BUSINESS WIRE 61 CRTX 61 Q2 Loss Narrows 61 TSX RVX